rdf:type |
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0030705,
umls-concept:C0040223,
umls-concept:C0162621,
umls-concept:C0178602,
umls-concept:C0360714,
umls-concept:C0806909,
umls-concept:C0936012,
umls-concept:C1274040,
umls-concept:C1280500,
umls-concept:C1514923
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-3-31
|
pubmed:abstractText |
Recent trials have shown that high-dose HMG-CoA reductase inhibitor (statin) therapy reduces cardiovascular events in high-risk subjects within weeks of initiating therapy. We investigated the effect of time to titration to maximum dose of statin therapy on cardiovascular events.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1175-3277
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
103-7
|
pubmed:dateRevised |
2009-7-28
|
pubmed:meshHeading |
pubmed-meshheading:19331438-Cardiovascular Diseases,
pubmed-meshheading:19331438-Cholesterol, LDL,
pubmed-meshheading:19331438-Databases, Factual,
pubmed-meshheading:19331438-Dose-Response Relationship, Drug,
pubmed-meshheading:19331438-Female,
pubmed-meshheading:19331438-Guideline Adherence,
pubmed-meshheading:19331438-Hospitals, Veterans,
pubmed-meshheading:19331438-Humans,
pubmed-meshheading:19331438-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19331438-Male,
pubmed-meshheading:19331438-Medical Records Systems, Computerized,
pubmed-meshheading:19331438-Middle Aged,
pubmed-meshheading:19331438-Practice Guidelines as Topic,
pubmed-meshheading:19331438-Retrospective Studies,
pubmed-meshheading:19331438-Risk Assessment,
pubmed-meshheading:19331438-Simvastatin,
pubmed-meshheading:19331438-Time Factors,
pubmed-meshheading:19331438-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Effect of time to titration to maximum dose of statins on cardiovascular outcomes: a retrospective analysis in high-risk patients.
|
pubmed:affiliation |
Richard L. Roudebush VA Medical Center, Indianapolis, Indiana 46202, USA.
|
pubmed:publicationType |
Journal Article
|